PD‐L1 inhibitors combined with whole brain radiotherapy in patients with small cell lung cancer brain metastases: Real‐world evidence

PD‐L1 inhibitors combined with whole brain radiotherapy in patients with small cell lung cancer brain metastases: Real‐world evidence

Abstract Background Numerous studies have demonstrated that brain metastases patients may benefit from intracranial radiotherapy combined with immune checkpoint inhibitors (ICIs). However, it is unclear whether this treatment is effective for patients with small cell lung cancer brain metastases (SC...

Full description

Bibliographic Details
Main Authors:	Litang Huang, Shen Chen, Hui Liu, Lu Meng, Chengxing Liu, Xiaoting Wu, Yingying Wang, Shilan Luo, Hongbin Tu, Chunlei Wang, Ming Zhang, Xiaomei Gong
Format:	Article
Language:	English
Published:	Wiley 2024-04-01
Series:	Cancer Medicine
Subjects:	extensive small cell lung cancer immunotherapy intracranial metastasis radiotherapy
Online Access:	https://doi.org/10.1002/cam4.7125

Similar Items

Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
by: Cecilia Jiang, et al.
Published: (2021-02-01)

Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy
by: Binwei Lin, et al.
Published: (2020-04-01)

Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases
by: Sofian Benkhaled, et al.
Published: (2024-03-01)

Whole Brain Radiotherapy Combined with Simultaneous Integrated Boost for Brain Metastases of Lung Cancer: Its Clinical Effectiveness and Prognosis
by: HE Jun, et al.
Published: (2018-08-01)

The association between graded prognostic assessment and the prognosis of brain metastases after whole brain radiotherapy: a meta-analysis
by: Xiaohan Geng, et al.
Published: (2024-01-01)

Hippocampal sparing in whole-brain radiotherapy for brain metastases: controversy, technology and the future
by: Rui Liu, et al.
Published: (2024-01-01)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
by: Xue-Yi Xie, et al.
Published: (2022-07-01)

Whole Brain Irradiation and Hypo-fractionation Radiotherapy for the Metastases in Non-small Cell Lung Cancer
by: Xingting GU, et al.
Published: (2016-04-01)

Survival and effective prognostic factors in lung cancer patients with brain metastases treated with whole brain radiotherapy
by: Bixin Ren, et al.
Published: (2021-03-01)

Reirradiation of Whole Brain for Recurrent Brain Metastases: A Case Report of Lung Cancer With 12-Year Survival
by: Minmin Li, et al.
Published: (2021-11-01)

Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone
by: Chen Xiu-jun, et al.
Published: (2011-12-01)

Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control
by: Naoyuki Kanayama, et al.
Published: (2022-12-01)

Research Advances in Intracranial Radiotherapy Combined with Immune Checkpoint Inhibitors on Lung Cancer Brain Metastasis
by: HE Qian, et al.
Published: (2020-04-01)

Brain metastases: Literature review
by: J.L. Navarro-Olvera, et al.
Published: (2017-01-01)

Analysis of Prognostic Factors in NSCLC Patients with Brain Metastases  Diagnosed by Constrast-enhanced MRI After Whole Brain Radiotherapy
by: Hui LIU, et al.
Published: (2011-09-01)

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan
by: Serigne N. Lo, et al.
Published: (2019-08-01)

Salvage Treatment for Progressive Brain Metastases in Breast Cancer
by: Mateusz Jacek Spałek, et al.
Published: (2022-02-01)

Hypofractionated Radiation Therapy for Large Brain Metastases
by: Giuseppina Laura Masucci
Published: (2018-10-01)

The Current and Future Treatment of Brain Metastases
by: Douglas A Hardesty, et al.
Published: (2016-05-01)

Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
by: Xiaofang Zhang, et al.
Published: (2022-10-01)

Multiple cerebral cavernous hemangiomas masquerading as hemorrhagic brain metastases
by: Parissa Feizi, M.D., et al.
Published: (2020-10-01)

Re-Whole Brain Radiotherapy May Be One of the Treatment Choices for Symptomatic Brain Metastases Patients
by: Takashi Ono, et al.
Published: (2022-10-01)

Resection of supratentorial brain metastases with intraoperative radiotherapy. Is it safe? Analysis and experiences of a single center cohort
by: Philipp Krauss, et al.
Published: (2022-12-01)

The Expanding Role of Radiosurgery for Brain Metastases
by: Mark O’Beirn, et al.
Published: (2018-08-01)

Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer
by: R.F. Yang, et al.
Published: (2017-11-01)

Choice of radiotherapy modality for the combined treatment of non-small cell lung cancer with brain metastases: whole-brain radiation therapy with simultaneous integrated boost or stereotactic radiosurgery
by: Xiaotao Dong, et al.
Published: (2023-09-01)

Intracranial dissemination in a primary small cell carcinoma of the brain: a case report and literature review
by: Yesheng Sun, et al.
Published: (2023-09-01)

Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases
by: Geoffrey Martinage, et al.
Published: (2019-03-01)

Unilateral hippocampal sparing during whole brain radiotherapy for multiple brain metastases: narrative and critical review
by: Petr Pospisil, et al.
Published: (2024-01-01)

Different Fractionation in Whole Brain Irradiation for Multiple Brain Metastases
by: Mona Mahmoud Sayed
Published: (2015-04-01)

Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational Approaches
by: Mario Levis, et al.
Published: (2023-09-01)

A Clinical Observation of Concomitant Therapy of Erlotinib and Whole Brain Radiotherapy in Patients of NSCLC Combined with Brain Metastases
by: Lihong ZHANG, et al.
Published: (2009-12-01)

Transfer Learning Approach to Vascular Permeability Changes in Brain Metastasis Post-Whole-Brain Radiotherapy
by: Chad A. Arledge, et al.
Published: (2023-05-01)

An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases
by: Shouliang Ding, et al.
Published: (2023-05-01)

Accuracy of MRI-CT registration in brain stereotactic radiotherapy: Impact of MRI acquisition setup and registration method
by: Siti Masitho, et al.
Published: (2022-11-01)

Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients
by: Tian Chen, et al.
Published: (2023-06-01)

A randomized controlled trial for evaluating pain response in patients with spinal metastases following local versus whole vertebral radiotherapy: study protocol for phase II clinical trial
by: Li Yuan, et al.
Published: (2022-06-01)

Brain metastasis of a malignant pleural mesothelioma: A case report and review of the literature
by: Myoung Soo Kim, et al.
Published: (2021-03-01)

Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center
by: Bolanle Adegboyega, et al.
Published: (2023-12-01)

Stereotactic radiosurgery versus whole-brain radiotherapy after resection of solitary brain metastasis: A systematic review and meta-analysis
by: Nikolaos Vlachos, et al.
Published: (2023-04-01)